S1PR1 and B-cell chronic lymphocytic leukemia: As expected, both treatments also induce significant enhancement of CLL migration to S1P (Fig. 3b), an effect that seemed reliant upon the level of S1PR1 expressed by CLL cells (Supplementary Figure 2b).